(VIANEWS) – NASDAQ Composite ended the session with TherapeuticsMD (TXMD) rising 6% to $1.06 on Wednesday while NASDAQ Composite jumped 0.92% to $14,631.95.
Today’s last reported volume for TherapeuticsMD is 3791100, 41.26% below its average volume of 6454550.
TherapeuticsMD’s last close was $1.00, 63.64% below its 52-week high of $2.75.
The company’s growth estimates for the ongoing quarter and the next is 42.1% and 25%, respectively.
Year-on-year quarterly revenue growth grew by 62.2%, now sitting on 72.49M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
TherapeuticsMD’s stock is considered to be overbought (>=80).
TherapeuticsMD’s Stock Yearly Top and Bottom Value
TherapeuticsMD’s stock is valued at $1.06 at 21:09 EST, way below its 52-week high of $2.75 and above its 52-week low of $0.98.
TherapeuticsMD’s Moving Average
TherapeuticsMD’s worth is way under its 50-day moving average of $1.19 and way under its 200-day moving average of $1.36.
More news about TherapeuticsMD (TXMD).